GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Roche Holding AG (OTCPK:RHHBY) » Definitions » Operating Margin %

Roche Holding AG (Roche Holding AG) Operating Margin %

: 18.88% (As of Dec. 2023)
View and export this data going back to 2002. Start your Free Trial

Operating Margin % is calculated as Operating Income divided by its Revenue. Roche Holding AG's Operating Income for the six months ended in Dec. 2023 was $6,511 Mil. Roche Holding AG's Revenue for the six months ended in Dec. 2023 was $34,488 Mil. Therefore, Roche Holding AG's Operating Margin % for the quarter that ended in Dec. 2023 was 18.88%.

Warning Sign:

Roche Holding AG operating margin has been in a 5-year decline. The average rate of decline per year is -1.2%.

The historical rank and industry rank for Roche Holding AG's Operating Margin % or its related term are showing as below:

RHHBY' s Operating Margin % Range Over the Past 10 Years
Min: 24.4   Med: 28.19   Max: 31.79
Current: 25.47


RHHBY's Operating Margin % is ranked better than
92.16% of 1020 companies
in the Drug Manufacturers industry
Industry Median: 6.38 vs RHHBY: 25.47

Roche Holding AG's 5-Year Average Operating Margin % Growth Rate was -1.20% per year.

Roche Holding AG's Operating Income for the six months ended in Dec. 2023 was $6,511 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2023 was $17,355 Mil.


Roche Holding AG Operating Margin % Historical Data

The historical data trend for Roche Holding AG's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Roche Holding AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Operating Margin %
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28.55 31.79 28.91 26.55 25.47

Roche Holding AG Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Operating Margin % Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.17 34.06 18.58 31.89 18.88

Competitive Comparison

For the Drug Manufacturers - General subindustry, Roche Holding AG's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Roche Holding AG Operating Margin % Distribution

For the Drug Manufacturers industry and Healthcare sector, Roche Holding AG's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Roche Holding AG's Operating Margin % falls into.



Roche Holding AG Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Roche Holding AG's Operating Margin % for the fiscal year that ended in Dec. 2023 is calculated as

Operating Margin %=Operating Income (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=17801.804 / 69890.148
=25.47 %

Roche Holding AG's Operating Margin % for the quarter that ended in Dec. 2023 is calculated as

Operating Margin %=Operating Income (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=6511.332 / 34487.743
=18.88 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Roche Holding AG  (OTCPK:RHHBY) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Roche Holding AG Operating Margin % Related Terms

Thank you for viewing the detailed overview of Roche Holding AG's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Roche Holding AG (Roche Holding AG) Business Description

Address
Grenzacherstrasse 124, Basel, CHE, 4070
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's best-selling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.

Roche Holding AG (Roche Holding AG) Headlines

From GuruFocus